HPSE and neoplasm: This result not only confirms compelling evidence that ties heparanase activity with tumor metastasis [5, 8–10, 15, 44], but also highlights the advantage of PG545 over conventional therapy in combining inhibition of tumor growth and metastasis in a setting most relevant to human patients.